(R)-Pentane-1,5-diyl bis(3-((R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)propanoate) dioxalate(CAS: 96687-52-4)

This compound falls under multiple regulatory guidelines. For safety, shipping, and storage, it is regulated under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and classified as a hazardous substance. In the European Union, it must comply with REACH regulations. In the USA, it is subject to FDA and EPA requirements for safety and environmental protection.

There are several alternatives to this compound in synthesis, including other isoquinoline derivatives with similar functionalities. Common alternatives include use of isoquinoline analogs, isomers, and different reagents such as 3,4-dimethoxybenzyl derivatives or other dioxalate salts.

Research trends for this compound indicate increasing interest in its potential as a pharmaceutical intermediate. Market trends show growing demand in specialized chemical and pharmaceutical industries, driven by its unique molecular structure and biological activity. Emerging research focuses on its use in developing new drugs and materials.

Waste containing this compound should be collected in appropriate containers and stored separately. It should be disposed of by a licensed hazardous waste facility via incineration or professional waste disposal methods. Ensure all handling and disposal comply with local, national, and international environmental regulations to prevent environmental contamination.